Jeffrey Ecsedy

Jeffrey Ecsedy

Company: Ikena Oncology

Job title: Chief Development Officer


Hippo Pathway & RAS: Relationship & Therapeutic Potential 10:30 am

Overview of Ikena efforts to target the Hippo pathway Hippo & RAS: pathways and mechanisms of resistance IK-930: Ikena’s TEAD inhibitorRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.